Epstein Secrets

ok at what I am up to, I have attached the full story. It is essentially the presentation I made in Moscow several years ago. I am now working with Russian Venture on the first, of what we both think will be a series of investments. As you can imagine, "the full story" is best told with a narrator, but maybe yo

opment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. EFTA00351823 OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to

ok at what I am up to, I have attached the full story. It is essentially the presentation I made in Moscow several years ago. I am now working with Russian Venture on the first, of what we both think will be a series of investments. As you can imagine, "the full story" is best told with a narrator, but maybe yo

opment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to risk and retur

ok at what I am up to, I have attached the full story. It is essentially the presentation I made in Moscow several years ago. I am now working with Russian Venture on the first, of what we both think will be a series of investments. As you can imagine, "the full story" is best told with a narrator, but maybe yo

pment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to risk and retur